Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP...
-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 10, 2022 3:05pm
Hemostemix information regarding intellectual property
Hemostemix Inc. recently announced the settlement of all litigation with aspire Health Service Inc., AJIA Global, LLC and Alan Jacobs, Jed Wood, Randi Wood, Blake Wood, Kyle Makofka, Reginald
...more
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Comment by
RamboOO7
on Jun 10, 2022 2:55pm
RE:RE:RE:Wow no volume !
Thanks for the heads up
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(36)
•••
WalterTheDawg
X
View Profile
View Bullboard History
Comment by
WalterTheDawg
on Jun 10, 2022 2:27pm
RE:RE:Wow no volume !
Holding pretty steady. I think we'll go up some once this PP closes and they give us an update on trial data and when we can expect results. Someone said PP should close next Friday
(4)
•••
JocetooBad
X
View Profile
View Bullboard History
Comment by
JocetooBad
on Jun 10, 2022 1:59pm
RE:Wow no volume !
people are waiting for news. No volume also means no sellers.
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 10, 2022 1:55pm
Bcel just dropped.
I didn't buy any yet
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 10, 2022 1:54pm
Wow no volume !
Looks like this will go down some. Still waiting !. Thought i missed the boat when it jumped to 37 cents awhile ago
(6)
•••
henery345
X
View Profile
View Bullboard History
Post by
henery345
on Jun 10, 2022 12:30pm
Hemostemix announce about closing of $2,750,000
Hemostemix Inc. has announced that it has closed its previously announced $2,750,000 non-brokered secured convertible debenture unit offering pursuant to which the Company issued 2,750 debenture units
...more
(6)
•••
henery345
X
View Profile
View Bullboard History
Post by
henery345
on Jun 10, 2022 12:21pm
$HMTXF get backs all its intellectual property
Hemostemix is now in possession of all of its intellectual property, including all HS 12-01 Phase II clinical trial data, all historical data from Hemostemix Israel, and the randomization tables that
...more
(6)
•••
henery345
X
View Profile
View Bullboard History
Post by
henery345
on Jun 10, 2022 12:16pm
Hemostemix owns over 91 patents
The Company owns 91 patents across five patent families titled: Regulating Stem Cells, In Vitro Techniques for use with Stem Cells, Production from Blood of Cells of Neural Lineage, and Automated Cell
...more
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 10, 2022 11:52am
Mr. Richard Groome focused on completing a series of financi
Mr. Richard Groome has joined Hemostemix Inc. as a special advisor to CEO, focusing on completing a series of financing transactions. https://www.newsfilecorp.com/redirect/BN4MbT0xgB
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 10, 2022 11:31am
Winner of World Economic Forum Technology Pioneer Award
Hemostemix is a publicly traded autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company developed and has published seven peer
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 10, 2022 11:30am
$HEM announcement related to the Stock Options Grant
Hemostemix Inc. announced that in accordance with its stock option plan, it has granted on February 28, 2022, subject to regulatory approval, a total of 1,494,269 stock options to purchase common
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 10, 2022 11:21am
Hemostemix informs regarding non-brokered private placement
Hemostemix Inc. announces a non-brokered private placement of up to 15 Million Units priced in the context of the market.
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 10, 2022 11:07am
$HMTXF. announce regarding non brokered private placement
Hemostemix Inc. announces a non-brokered private placement of up to 15 Million Units priced in the context of the market. https://www.newsfilecorp.com/redirect/WrjBBuqKvY
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 10, 2022 10:48am
Hemostemix and the settlement agreement
Hemostemix Inc. announced the settlement of all pending litigation with Aspire and certain other companies.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >